Skip to main content
Caplight Logo









Bios Line Holding

Bios Line Holding

Overview

Bios Line Holding S.r.l. is the holding company and family office for the founders of Bios Line S.p.A., a manufacturer of food supplements and natural cosmetics. The holding company makes strategic investments in various companies.

Year Founded

2016

Portfolio Companies

2

Investments

Bios Line Holding investments
CompanyDateStageLead
NeuranixJun 2022VC RoundCo-investor
FreedomeOct 2023Series A ExtensionCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Bios Line Holding based?

Bios Line Holding is headquartered in Italy.

When was Bios Line Holding founded?

Bios Line Holding was founded in 2016.

How many portfolio companies does Bios Line Holding have?

Bios Line Holding has 2 portfolio companies in Caplight's dataset.

What are some companies in Bios Line Holding's portfolio?

Portfolio companies visible on Caplight include Neuranix, Freedome.

What was Bios Line Holding's most recent investment shown here?

Bios Line Holding's most recent investment in this portfolio sample was in Freedome in 2023.

What sectors does Bios Line Holding focus on?

Bios Line Holding focuses on Healthcare & Life Sciences, Consumer & Commerce.

What company stages does Bios Line Holding focus on?

Bios Line Holding typically invests at the Early stage.

Firmographic Details

HeadquartersItaly
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?